http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2324867-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3873abaff397acbfffa1595a12cfef41 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-72 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 |
filingDate | 1999-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20397138534e9f03821f0bb42359025a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2c051503ab2d3311fa1766de66e6011 |
publicationDate | 1999-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2324867-A1 |
titleOfInvention | Bradykinin b1 receptor as marker for inflammatory diseases |
abstract | The present invention relates to a marker for inflammatory diseases, a tool to measure inflammatory disease activity and to a drug screening assay of therapeutical agents for the treatment of inflammatory diseases. The marker for inflammatory diseases includes bradykinin B1 receptor. The invention also relates to a method for the diagnosis of inflammatory diseases in a patient, which comprises determining the presence of bradykinin B1 receptor in a biological sample of said patient, wherein the presence of bradykinin B1 receptor is indicative of an inflammatory disease. |
priorityDate | 1998-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 232.